ArticleEcancermedicalscience2020
New journal authorship criteria: how
Article in Ecancermedicalscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic Review of Cancer Research Output From Africa, With Zambia as an Example.JCO global oncology · 2021Pooled it
- Authorship of Publications Supported by NCI-Funded Grants Involving Low- and Middle-Income Countries.JAMA network open · 2024Article
- Leveraging national and global political determinants of health to promote equity in cancer care.Journal of the National Cancer Institute · 2023Article
- Prostate cancer clinical trials in low- and middle-income countries.Ecancermedicalscience · 2023Article
- Cancer research across Africa: a comparative bibliometric analysis.BMJ global health · 2022Article
- To parachute or not.Ecancermedicalscience · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In order to reduce the increasing cancer burden in Lower and Middle Income Countries (LMICs), oncology journals must support authors from underserved settings to become fully involved in the global publication system, without facing barriers to publishing their research such as geographical bias and lack of funding. ecancermedicalscience's goal has always been to publish high-quality research which contributes towards narrowing the gap between those who have access to adequate cancer prevention, treatment and care and those who do not. The time is now right for the journal to take new steps in proactively supporting authors from LMICs and the global partnerships that are vital to increasing the availability of resource-appropriate data. With this in mind, ecancermedicalscience will only be accepting submissions which feature at least one author from an LMIC, or which have a significant impact on under-resourced settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.